Greenwich LifeSciences
GLSI
36 hedge funds and large institutions have $31.9M invested in Greenwich LifeSciences in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
86% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 7
20% more funds holding
Funds holding: 30 → 36 (+6)
0% more ownership
Funds ownership: 6.29% → 6.29% (+0%)
12% less capital invested
Capital invested by funds: $36.3M → $31.9M (-$4.42M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.18M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.16M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$1.02M |
| 4 |
Millennium Management
New York
|
+$631K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$531K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$5.51M |
| 2 |
Morgan Stanley
New York
|
-$322K |
| 3 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$132K |
| 4 |
JP Morgan Chase
New York
|
-$126K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $64K | +$1.13K | +27 | +2% |
|
|
DWA
27
Dorsey Wright & Associates
Pasadena,
California
| $44K | +$46.7K | +1,118 | New |
|
|
SO
28
STRS Ohio
Columbus,
Ohio
| $35K | – | – | – |
|
|
29
Morgan Stanley
New York
| $27K | -$322K | -7,704 | -92% |
|
|
S
30
SignatureFD
Atlanta,
Georgia
| $22K | – | – | – |
|
|
NFSG
31
Newbridge Financial Services Group
Boca Raton,
Florida
| $20K | +$20.9K | +500 | New |
|
32
Legal & General Group
London,
United Kingdom
| $17K | – | – | – |
|
|
AIP
33
Ameritas Investment Partners
Lincoln,
Nebraska
| $12K | – | – | – |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| $10K | -$1.71K | -41 | -14% |
|
35
Wells Fargo
San Francisco,
California
| $5K | – | – | – |
|
|
NSIM
36
North Star Investment Management
Chicago,
Illinois
| $2K | – | – | – |
|
|
37
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$4K | -100 | Closed |
|
GLSI Hedge Fund Activity: Q3 2021 in Review
36 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q3 2021, worth a combined $31.9M — down 12% from $36.3M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new GLSI positions and 1 closed out — a net gain of 6 holders — while 13 added to existing stakes and 7 trimmed.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $1.18M. The largest seller was Invesco, cutting an estimated $5.51M.
- 36 institutional investors held Greenwich LifeSciences (GLSI) as of Q3 2021, up from 30 in Q2 2021.
- Funds reported $31.9M of Greenwich LifeSciences stock for Q3 2021, down 12% quarter-over-quarter.
- 7 funds opened new Greenwich LifeSciences positions in Q3 2021 and 1 closed out, a net change of +6 holders.
- The largest Greenwich LifeSciences buyer in Q3 2021 was Bank of Montreal, an estimated $1.18M added.
- The largest Greenwich LifeSciences seller in Q3 2021 was Invesco, an estimated $5.51M sold.
Based on aggregated 13F filings for Q3 2021.